Citigroup Maintains Buy on RH, Lowers Price Target to $437
RHTelsey Advisory Group Maintains Outperform on RH, Lowers Price Target to $420
RHUBS Maintains Neutral on RH, Lowers Price Target to $250
RHWells Fargo Maintains Overweight on RH, Lowers Price Target to $375
RHRH Is Poised For 'Positive Inflection' In 2025 Earnings: Analyst
RHMorgan Stanley upgrades RH to Overweight with $530 price target, citing positive inflection and long-term fundamentals.
Morgan Stanley Upgrades RH to Overweight, Raises Price Target to $530
RHRH Demand Soars In December: Analyst Predicts Big Moves In 2025
RHRH reported Q3 earnings miss but raised guidance. Demand trends have been better than expected, leading to market share gains and an upgrade by analyst Cristina Fernández.
Telsey Advisory Group Upgrades RH to Outperform, Raises Price Target to $500
RHWedbush Reiterates Neutral on RH, Maintains $320 Price Target
RHJP Morgan Maintains Overweight on RH, Raises Price Target to $325
RHBarclays Maintains Overweight on RH, Raises Price Target to $328
RHThese 2 Analysts Slash Price Targets On RH Following Q2 Results
RHRH (NYSE: RH) reported weaker-than-expected earnings for its second quarter, while sales exceeded estimates.
RH shares rose 4.1% to $272.30 on Friday.
Morgan Stanley Maintains Equal-Weight on RH, Lowers Price Target to $325
RHJefferies Maintains Buy on RH, Lowers Price Target to $375
RHRH Q2 Adj. EPS $8.08 Misses $8.48 Estimate, Sales $991.62M Beat $968.42M Estimate
RHWhy RH Is Poised For Rally After Earnings Release
RHRH (NYSE: RH) is scheduled to report its quarterly results on Thursday after the bell.